• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage, Cerebral (1889); Neurological Deficit/Dysfunction (1982); Thrombosis (2100); Therapeutic Response, Decreased (2271)
Event Date 02/06/2017
Event Type  Injury  
Manufacturer Narrative
Citation: adeeb, n.Adeeb, j.M.Moore, c.J.Griessenauer, p.M.Foreman, h.Shallwani, a.A.Dmytriw, h.Shakir, a.H.Siddiqui, e.I.Levy, j.M.Davies, m.R.Harrigan, a.J.Thomas, and c.S.Ogilvy (2017).Treatment of tandem internal carotid artery aneurysms using a single pipeline embolization device: evaluation of safety and efficacy.American journal of neuroradiology.Doi:10.3174/ajnr.A5221.The purpose of this article was to retrospectively analyze consecutive aneurysms treated with the pipeline embolization device (ped) between 2009 and 2016.Cases included aneurysm of the ica treated with a single ped, divided into tandem vs.Solitaire.The solitary group, (median age 58 years) underwent 184 ped procedures for 184 aneurysms.The tandem group, consisting of more than 1 intracranial ica aneurysm within the same anatomic segment or involving adjacent segments (median age 50.5 years) underwent 34 procedures for 78 aneurysms.The authors conclude that tandem aneurysms of the ica can be treated with a single pipeline embolization device with high rates of complete occlusion.There were no mortalities in either group.The cause of the reported events cannot be reliably determined; however, per the reported information, review of ifu, and review of literature to investigate the complaint, the most likely cause for the reported complications is related to the embolization procedures and overall patient conditions.Additional information has been requested, however no response has been received.Should the information become available a supplemental report will be submitted.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information through literature review that of patients treated with the pipeline embolization device (peds), either for solitary or tandem aneurysms, complications were encountered.The complications reported in the study of 268 aneurysms treated with pipelines embolization devices were as follows: retreatment was required in 4.9% of patients treated for solitary aneurysms, and in 5.7% of patients with tandem aneurysms; mrs reportedly worsened in 7% of patients in the solitary aneurysm group; symptomatic thromboembolic complications were encountered in 2.7% solitary aneurysms, and 8.8% tandem aneurysm procedures; symptoms were permanent as a result of ischemic stroke in 1.6% and 2.9% of the procedures respectively; one procedure for treatment of a solitary aneurysm was complicated by both an ischemic stroke and an intraparenchymal hemorrhage.There were no mortalities reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE EMBOLIZATION DEVICE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9498373700
MDR Report Key6773561
MDR Text Key82039802
Report Number2029214-2017-00945
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100018.S004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 07/25/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/08/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/25/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-